CUHK Medicine shared on LinkedIn:
“New appointment: We are delighted to announce that our Dean, Professor Philip Chiu, has been appointed to concurrently serve as Associate Vice-President (Medical Affairs) and Dean of Medicine at CUHK-Shenzhen (香港中文大学（深圳）医学院 CUHK-Shenzhen MEDICINE).
The appointments will take effect on 1 November 2026, with a term aligned with his current tenure as Dean of CUHK Medicine.
This marks a significant strategic move under CUHK’s ‘One Brand, Two Campuses’ vision. It will further strengthen the capabilities and advantages of both campuses in medical education, translational research and clinical excellence.
By leveraging the crucial clinical and research platforms provided by the two CUHK medical centres in Hong Kong and Shenzhen, CUHK aims to advance medical innovation and the internationalisation of medical education, cultivate top global healthcare professionals, elevate regional healthcare standards and serve the broader GBA.
The initiative is also aligned with the National 15th Five-Year Plan and the First Five-Year Plan of the Hong Kong Special Administrative Region.
Professor Chiu expresses his gratitude and shares his vision for the future:
‘Strengthening collaboration between Hong Kong and Shenzhen in medical education and research is key to driving high-quality healthcare development in the Greater Bay Area and across the wider nation.
I will devote my full efforts to fostering deep-level synergy between the two medical schools across education, research and clinical innovation to achieve a powerful ‘1 + 1 > 2’ effect.
This appointment will enable CU Medicine to further expand its clinical data and translational research platforms, reinforcing Hong Kong’s position as an international hub for medical innovation.
At the same time, it will accelerate the internationalisation of the School of Medicine at CUHK-Shenzhen, attract top-tier medical talent and drive breakthroughs at the frontiers of medicine.
Through close collaboration between the two campuses, we aim to align with the national ‘Healthy China’ agenda and the Greater Bay Area’s innovation development strategy, jointly building a globally influential hub for medical innovation and talent development.’
You can also read:
CUHK Medicine’s Clinical Medicine Ranks 11th Globally and 1st in Asia in ShanghaiRanking’s 2026
